Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation

Chronic intermittent hypoxia (CIH) induced by sleep-disordered breathing (SDB) is a key factor involved in cognitive dysfunction (CD). Increasing evidence has shown that atractylon (ATR) has anti-inflammatory effects. However, it remains unclear if ATR has a protective effect against SDB-induced ner...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yan, Liu, Xiuxiu, Tan, Dan, Jiang, Zhiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Immunology & Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295624/
https://www.ncbi.nlm.nih.gov/pubmed/32490526
http://dx.doi.org/10.1042/BSR20192800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295624/
https://www.ncbi.nlm.nih.gov/pubmed/32490526
http://dx.doi.org/10.1042/BSR20192800

Ejemplares similares